Very good summary reader1
The result is utter disappointment. Let's face it.
WP had not expected this result otherwise why you schedule 9 to 10.45 AEST and just give a simple read and finish in 20 minutes.
A lot of doubt exists now how the next phase will go. Hopefully WP understand trying to tap more money from SH would not be an acceptable option. Partner it or write off. You can't keep elephant in the room if you don't enough food to feed it.
I'm not after vaccine so no very great deal to me. The only thing I fail to understand is why the company pouring dollars after dollars to increase stake in vaccine business. They should be content with the stake they had in vaccine business before trying to take the whole business and pouring every single dollar.
In terms of sp 3-5 mil shares needs to be flushed out from the punter who jumped in for quick trade. Professional does know how to do it. As price is hovering around multi year low I don't see much downside from here. Probably bottom has been placed at 30c.
Gltah
- Forums
- ASX - By Stock
- AVR
- Ann: Admedus Releases Results of HSV-2 Phase IIa Study
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-90
-
- There are more pages in this discussion • 261 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.50 |
Change
0.000(0.00%) |
Mkt cap ! $243.1M |
Open | High | Low | Value | Volume |
$11.50 | $11.50 | $11.00 | $344.4K | 30.43K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $11.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.50 | 4417 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 11.300 |
1 | 458 | 11.220 |
1 | 500 | 11.200 |
2 | 980 | 11.100 |
1 | 1000 | 11.010 |
Price($) | Vol. | No. |
---|---|---|
11.500 | 4417 | 1 |
11.830 | 500 | 1 |
11.850 | 164 | 1 |
11.900 | 1000 | 1 |
12.000 | 500 | 1 |
Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online